RG
BOLD

Redmile Group’s Boundless Bio BOLD Stock Holding History

Redmile Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-245,458
Closed -$302K – 43
2025
Q3 		$302K Sell
245,458
-343,576
-58% -$397K 0.03% 40
2025
Q2 		$595K Sell
589,034
-136,170
-19% -$181K 0.06% 46
2025
Q1 		$1.1M Sell
725,204
-15,000
-2% -$31.1K 0.1% 54
2024
Q4 		$2.15M Sell
740,204
-283,344
-28% -$826K 0.15% 54
2024
Q3 		$3.55M Sell
1,023,548
-11,035
-1% -$40K 0.21% 50
2024
Q2 		$4M Sell
1,034,583
-79,451
-7% -$759K 0.24% 48
2024
Q1 		$15.9M Buy
+1,114,034
New +$15.9M 0.58% 45

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Redmile Group's BOLD Position: Q4 2025 in Review

Redmile Group sold out of Boundless Bio (BOLD) in Q4 2025, closing a stake of 245,458 shares — an estimated $302K sold.

Redmile Group first reported a position in BOLD in Q1 2024 and held it in 7 quarters. The position peaked at $15.9M in Q1 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q4 2025.

  • Redmile Group reported no remaining Boundless Bio position as of Q4 2025 after selling out during the quarter.
  • Redmile Group sold 245,458 Boundless Bio shares in Q4 2025, an estimated $302K.
  • Redmile Group first reported a position in Boundless Bio in Q1 2024 and held it in 7 quarters.
  • Redmile Group's Boundless Bio position peaked at $15.9M in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q4 2025.

Based on Redmile Group's 13F filing for Q4 2025, filed 17 Feb 2026.